Conserved RB functions in development and tumor suppression

Protein and Cell

Volumn 2, Issue 11, 2011, Pages 864-878

  Gordon, Gabriel M ^a   Du, Wei ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

cell cycle; chromatin modification; Drosophila Rbf; E2F; RB

Indexed keywords

CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE INHIBITOR 2A; PROTEIN P53; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR E2F;

AMINO TERMINAL SEQUENCE; ANEUPLOIDY; BINDING AFFINITY; CANCER INHIBITION; CARBOXY TERMINAL SEQUENCE; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL CYCLE PROGRESSION; CELL CYCLE REGULATION; CELL CYCLE S PHASE; CELL DEATH; CELL DIFFERENTIATION; CELL PROLIFERATION; CHROMATIN CONDENSATION; DNA REPLICATION; DROSOPHILA MELANOGASTER; ENZYME INACTIVATION; EPIGENETICS; GENE LOCUS; GENETIC CONSERVATION; GENOMIC INSTABILITY; HUMAN; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; PROSTATE CANCER; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN MODIFICATION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION;

DROSOPHILA MELANOGASTER;

EID: 84856140976     PISSN: 1674800X     EISSN: 16748018     Source Type: Journal    
DOI: 10.1007/s13238-011-1117-z     Document Type: Review

References (151)

1. Attwooll, C., Lazzerini Denchi, E., and Helin, K. (2004). The E2F family: specific functions and overlapping interests. Embo J 23, 4709-4716.
2. Bartkova, J., Rezaei, N., Liontos, M., Karakaidos, P., Kletsas, D., Issaeva, N., Vassiliou, L. V., Kolettas, E., Niforou, K., Zoumpourlis, V. C., et al. (2006). Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints. Nature 444, 633-637.
3. Bates, S., Phillips, A. C., Clark, P. A., Stott, F., Peters, G., Ludwig, R. L., and Vousden, K. H. (1998). p14ARF links the tumour suppressors RB and p53. Nature 395, 124-125.
4. Benevolenskaya, E. V., Murray, H. L., Branton, P., Young, R. A., and Kaelin, W. G. Jr. (2005). Binding of pRB to the PHD protein RBP2 promotes cellular differentiation. Mol Cell 18, 623-635.
5. Bergmann, A., Agapite, J., McCall, K., and Steller, H. (1998). The Drosophila gene hid is a direct molecular target of Ras-dependent survival signaling. Cell 95, 331-341.
6. Bester, A. C., Roniger, M., Oren, Y. S., Im, M. M., Sarni, D., Chaoat, M., Bensimon, A., Zamir, G., Shewach, D. S., and Kerem, B. (2011). Nucleotide deficiency promotes genomic instability in early stages of cancer development. Cell 145, 435-446.
7. Bier, E. (2005). Drosophila, the golden bug, emerges as a tool for human genetics. Nat Rev Genet 6, 9-23.
8. Binné, U. K., Classon, M. K., Dick, F. A., Wei, W., Rape, M., Kaelin, W. G. Jr, Näär, A. M., and Dyson, N. J. (2007). Retinoblastoma protein and anaphase-promoting complex physically interact and functionally cooperate during cell-cycle exit. Nat Cell Biol 9, 225-232.
9. Bosco, E. E., Wang, Y., Xu, H., Zilfou, J. T., Knudsen, K. E., Aronow, B. J., Lowe, S. W., and Knudsen, E. S. (2007). The retinoblastoma tumor suppressor modifies the therapeutic response of breast cancer. J Clin Invest 117, 218-228.
10. Bourgo, R. J., Thangavel, C., Ertel, A., Bergseid, J., McClendon, A. K., Wilkens, L., Witkiewicz, A. K., Wang, J. Y., and Knudsen, E. S. (2011). RB restricts DNA damage-initiated tumorigenesis through an LXCXE-dependent mechanism of transcriptional control. Mol Cell 43, 663-672.
11. Bunz, F., Dutriaux, A., Lengauer, C., Waldman, T., Zhou, S., Brown, J. P., Sedivy, J. M., Kinzler, K. W., and Vogelstein, B. (1998). Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science 282, 1497-1501.
12. Burke, J. R., Deshong, A. J., Pelton, J. G., and Rubin, S. M. (2010). Phosphorylation-induced conformational changes in the retinoblastoma protein inhibit E2F transactivation domain binding. J Biol Chem 285, 16286-16293.
13. Burkhart, D. L., and Sage, J. (2008). Cellular mechanisms of tumour suppression by the retinoblastoma gene. Nat Rev Cancer 8, 671-682.
14. Buttitta, L. A., Katzaroff, A. J., Perez, C. L., de la Cruz, A., and Edgar, B. A. (2007). A double-assurance mechanism controls cell cycle exit upon terminal differentiation in Drosophila. Dev Cell 12, 631-643.
15. Calo, E., Quintero-Estades, J. A., Danielian, P. S., Nedelcu, S., Berman, S. D., and Lees, J. A. (2010). Rb regulates fate choice and lineage commitment in vivo. Nature 466, 1110-1114.
16. Chauveinc, L., Mosseri, V., Quintana, E., Desjardins, L., Schlienger, P., Doz, F., and Dutrillaux, B. (2001). Osteosarcoma following retinoblastoma: age at onset and latency period. Ophthalmic Genet 22, 77-88.
17. Chen, D., Pacal, M., Wenzel, P., Knoepfler, P. S., Leone, G., and Bremner, R. (2009a). Division and apoptosis of E2f-deficient retinal progenitors. Nature 462, 925-929.
18. Chen, H. Z., Tsai, S. Y., and Leone, G. (2009b). Emerging roles of E2Fs in cancer: an exit from cell cycle control. Nat Rev Cancer 9, 785-797.
19. Chicas, A., Wang, X., Zhang, C., McCurrach, M., Zhao, Z., Mert, O., Dickins, R. A., Narita, M., Zhang, M., and Lowe, S. W. (2010). Dissecting the unique role of the retinoblastoma tumor suppressor during cellular senescence. Cancer Cell 17, 376-387.
20. Chin, L., Hahn, W. C., Getz, G., and Meyerson, M. (2011). Making sense of cancer genomic data. Genes Dev 25, 534-555.
21. Chong, J. L., Wenzel, P. L., Sáenz-Robles, M. T., Nair, V., Ferrey, A., Hagan, J. P., Gomez, Y. M., Sharma, N., Chen, H. Z., Ouseph, M., et al. (2009). E2f1-3 switch from activators in progenitor cells to repressors in differentiating cells. Nature 462, 930-934.
22. Christensen, J., Agger, K., Cloos, P. A., Pasini, D., Rose, S., Sennels, L., Rappsilber, J., Hansen, K. H., Salcini, A. E., and Helin, K. (2007). RBP2 belongs to a family of demethylases, specific for tri-and dimethylated lysine 4 on histone 3. Cell 128, 1063-1076.
23. Claudio, P. P., Zamparelli, A., Garcia, F. U., Claudio, L., Ammirati, G., Farina, A., Bovicelli, A., Russo, G., Giordano, G. G., McGinnis, D. E., et al. (2002). Expression of cell-cycle-regulated proteins pRb2/ p130, p107, p27(kip1), p53, mdm-2, and Ki-67 (MIB-1) in prostatic gland adenocarcinoma. Clin Cancer Res 8, 1808-1815.
24. Coschi, C. H., Martens, A. L., Ritchie, K., Francis, S. M., Chakrabarti, S., Berube, N. G., and Dick, F. A. (2010). Mitotic chromosome condensation mediated by the retinoblastoma protein is tumorsuppressive. Genes Dev 24, 1351-1363.
25. Dannenberg, J. H., Schuijff, L., Dekker, M., van der Valk, M., and te Riele, H. (2004). Tissue-specific tumor suppressor activity of retinoblastoma gene homologs p107 and p130. Genes Dev 18, 2952-2962.
26. de Nooij, J. C., Letendre, M. A., and Hariharan, I. K. (1996). A cyclindependent kinase inhibitor, Dacapo, is necessary for timely exit from the cell cycle during Drosophila embryogenesis. Cell 87, 1237-1247.
27. Di Micco, R., Fumagalli, M., Cicalese, A., Piccinin, S., Gasparini, P., Luise, C., Schurra, C., Garre', M., Nuciforo, P. G., Bensimon, A., et al. (2006). Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication. Nature 444, 638-642.
28. Dick, F. A., and Mymryk, J. S. (2011). Sweet DREAMs for Hippo. Genes Dev 25, 889-894.
29. Dimova, D. K., Stevaux, O., Frolov, M. V., and Dyson, N. J. (2003). Cell cycle-dependent and cell cycle-independent control of transcription by the Drosophila E2F/RB pathway. Genes Dev 17, 2308-2320.
30. Du, W., and Dyson, N. (1999). The role of RBF in the introduction of G1 regulation during Drosophila embryogenesis. EMBO J 18, 916-925.
31. Du, W., and Pogoriler, J. (2006). Retinoblastoma family genes. Oncogene 25, 5190-5200.
32. Dynlacht, B. D., Flores, O., Lees, J. A., and Harlow, E. (1994). Differential regulation of E2F transactivation by cyclin/cdk2 complexes. Genes Dev 8, 1772-1786.
33. el-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., and Vogelstein, B. (1993). WAF1, a potential mediator of p53 tumor suppression. Cell 75, 817-825.
34. Ewen, M. E., Sluss, H. K., Sherr, C. J., Matsushime, H., Kato, J., and Livingston, D. M. (1993). Functional interactions of the retinoblastoma protein with mammalian D-type cyclins. Cell 73, 487-497.
35. Feinberg, A. P., and Tycko, B. (2004). The history of cancer epigenetics. Nat Rev Cancer 4, 143-153.
36. Ferbeyre, G., de Stanchina, E., Querido, E., Baptiste, N., Prives, C., and Lowe, S. W. (2000). PML is induced by oncogenic ras and promotes premature senescence. Genes Dev 14, 2015-2027.
37. Ferres-Marco, D., Gutierrez-Garcia, I., Vallejo, D. M., Bolivar, J., Gutierrez-Aviño, F. J., and Dominguez, M. (2006). Epigenetic silencers and Notch collaborate to promote malignant tumours by Rb silencing. Nature 439, 430-436.
38. Firth, L. C., and Baker, N. E. (2005). Extracellular signals responsible for spatially regulated proliferation in the differentiating Drosophila eye. Dev Cell 8, 541-551.
39. Foijer, F., Wolthuis, R. M., Doodeman, V., Medema, R. H., and te Riele, H. (2005). Mitogen requirement for cell cycle progression in the absence of pocket protein activity. Cancer Cell 8, 455-466.
40. Friend, S. H., Bernards, R., Rogelj, S., Weinberg, R. A., Rapaport, J. M., Albert, D. M., and Dryja, T. P. (1986). A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature 323, 643-646.
41. Giangrande, P. H., Zhu, W., Schlisio, S., Sun, X., Mori, S., Gaubatz, S., and Nevins, J. R. (2004). A role for E2F6 in distinguishing G1/Sand G2/M-specific transcription. Genes Dev 18, 2941-2951.
42. Ginsberg, D. (2002). E2F1 pathways to apoptosis. FEBS Lett 529, 122-125.
43. Gonzalo, S., García-Cao, M., Fraga, M. F., Schotta, G., Peters, A. H., Cotter, S. E., Eguía, R., Dean, D. C., Esteller, M., Jenuwein, T., et al. (2005). Role of the RB1 family in stabilizing histone methylation at constitutive heterochromatin. Nat Cell Biol 7, 420-428.
44. Goodrich, D. W. (2003). How the other half lives, the amino-terminal domain of the retinoblastoma tumor suppressor protein. J Cell Physiol 197, 169-180.
45. Gordon, G. M., and Du, W. (2011). Targeting Rb inactivation in cancers by synthetic lethality. Am J Cancer Res 1, 773-786.
46. Hallstrom, T. C., Mori, S., and Nevins, J. R. (2008). An E2F1-dependent gene expression program that determines the balance between proliferation and cell death. Cancer Cell 13, 11-22.
47. Harper, J. W., Adami, G. R., Wei, N., Keyomarsi, K., and Elledge, S. J. (1993). The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75, 805-816.
48. Harrington, L. S., Findlay, G. M., Gray, A., Tolkacheva, T., Wigfield, S., Rebholz, H., Barnett, J., Leslie, N. R., Cheng, S., Shepherd, P. R., et al. (2004). The TSC1-2 tumor suppressor controls insulin-PI3K signaling via regulation of IRS proteins. J Cell Biol 166, 213-223.
49. Hassler, M., Singh, S., Yue, W. W., Luczynski, M., Lakbir, R., Sanchez-Sanchez, F., Bader, T., Pearl, L. H., and Mittnacht, S. (2007). Crystal structure of the retinoblastoma protein N domain provides insight into tumor suppression, ligand interaction, and holoprotein architecture. Mol Cell 28, 371-385.
50. Hernando, E., Nahlé, Z., Juan, G., Diaz-Rodriguez, E., Alaminos, M., Hemann, M., Michel, L., Mittal, V., Gerald, W., Benezra, R., et al. (2004). Rb inactivation promotes genomic instability by uncoupling cell cycle progression from mitotic control. Nature 430, 797-802.
51. Hiebert, S. W. (1993). Regions of the retinoblastoma gene product required for its interaction with the E2F transcription factor are necessary for E2 promoter repression and pRb-mediated growth suppression. Mol Cell Biol 13, 3384-3391.
52. Hinds, P. W., Mittnacht, S., Dulic, V., Arnold, A., Reed, S. I., and Weinberg, R. A. (1992). Regulation of retinoblastoma protein functions by ectopic expression of human cyclins. Cell 70, 993-1006.
53. Hirschi, A., Cecchini, M., Steinhardt, R. C., Schamber, M. R., Dick, F. A., and Rubin, S. M. (2010). An overlapping kinase and phosphatase docking site regulates activity of the retinoblastoma protein. Nat Struct Mol Biol 17, 1051-1057.
54. Hsieh, T. C., Nicolay, B. N., Frolov, M. V., and Moon, N. S. (2010). Tuberous sclerosis complex 1 regulates dE2F1 expression during development and cooperates with RBF1 to control proliferation and survival. PLoS Genet 6, e1001071.
55. Hu, N., Gutsmann, A., Herbert, D. C., Bradley, A., Lee, W. H., and Lee, E. Y. (1994). Heterozygous Rb-1 delta 20/+ mice are predisposed to tumors of the pituitary gland with a nearly complete penetrance. Oncogene 9, 1021-1027.
56. Ianari, A., Natale, T., Calo, E., Ferretti, E., Alesse, E., Screpanti, I., Haigis, K., Gulino, A., and Lees, J. A. (2009). Proapoptotic function of the retinoblastoma tumor suppressor protein. Cancer Cell 15, 184-194.
57. Isaac, C. E., Francis, S. M., Martens, A. L., Julian, L. M., Seifried, L. A., Erdmann, N., Binné, U. K., Harrington, L., Sicinski, P., Bérubé, N. G., et al. (2006). The retinoblastoma protein regulates pericentric heterochromatin. Mol Cell Biol 26, 3659-3671.
58. Ishida, S., Huang, E., Zuzan, H., Spang, R., Leone, G., West, M., and Nevins, J. R. (2001). Role for E2F in control of both DNA replication and mitotic functions as revealed from DNA microarray analysis. Mol Cell Biol 21, 4684-4699.
59. Iwase, S., Lan, F., Bayliss, P., de la Torre-Ubieta, L., Huarte, M., Qi, H. H., Whetstine, J. R., Bonni, A., Roberts, T. M., and Shi, Y. (2007). The X-linked mental retardation gene SMCX/JARID1C defines a family of histone H3 lysine 4 demethylases. Cell 128, 1077-1088.
60. Julien, L. A., Carriere, A., Moreau, J., and Roux, P. P. (2010). mTORC1-activated S6K1 phosphorylates Rictor on threonine 1135 and regulates mTORC2 signaling. Mol Cell Biol 30, 908-921.
61. Kaelin, W. G. Jr. (2005). The concept of synthetic lethality in the context of anticancer therapy. Nat Rev Cancer 5, 689-698.
62. Kamijo, T., Weber, J. D., Zambetti, G., Zindy, F., Roussel, M. F., and Sherr, C. J. (1998). Functional and physical interactions of the ARF tumor suppressor with p53 and Mdm2. Proc Natl Acad Sci U S A 95, 8292-8297.
63. Kanber, D., Berulava, T., Ammerpohl, O., Mitter, D., Richter, J., Siebert, R., Horsthemke, B., Lohmann, D., and Buiting, K. (2009). The human retinoblastoma gene is imprinted. PLoS Genet 5, e1000790.
64. Kato, J., Matsushime, H., Hiebert, S. W., Ewen, M. E., and Sherr, C. J. (1993). Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4. Genes Dev 7, 331-342.
65. Kaye, F. J., and Harbour, J. W. (2004). For whom the bell tolls: susceptibility to common adult cancers in retinoblastoma survivors. J Natl Cancer Inst 96, 342-343.
66. Klose, R. J., Yan, Q., Tothova, Z., Yamane, K., Erdjument-Bromage, H., Tempst, P., Gilliland, D. G., Zhang, Y., and Kaelin, W. G. Jr. (2007). The retinoblastoma binding protein RBP2 is an H3K4 demethylase. Cell 128, 889-900.
67. Knudsen, E. S., and Wang, J. Y. (2010). Targeting the RB-pathway in cancer therapy. Clin Cancer Res 16, 1094-1099.
68. Knudson, A. G. Jr. (1971). Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci U S A 68, 820-823.
69. Korenjak, M., Taylor-Harding, B., Binné, U. K., Satterlee, J. S., Stevaux, O., Aasland, R., White-Cooper, H., Dyson, N., and Brehm, A. (2004). Native E2F/RBF complexes contain Mybinteracting proteins and repress transcription of developmentally controlled E2F target genes. Cell 119, 181-193.
70. Lalande, M., Dryja, T. P., Schreck, R. R., Shipley, J., Flint, A., and Latt, S. A. (1984). Isolation of human chromosome 13-specific DNA sequences cloned from flow sorted chromosomes and potentially linked to the retinoblastoma locus. Cancer Genet Cytogenet 13, 283-295.
71. Lane, M. E., Sauer, K., Wallace, K., Jan, Y. N., Lehner, C. F., and Vaessin, H. (1996). Dacapo, a cyclin-dependent kinase inhibitor, stops cell proliferation during Drosophila development. Cell 87, 1225-1235.
72. Laurie, N. A., Donovan, S. L., Shih, C. S., Zhang, J., Mills, N., Fuller, C., Teunisse, A., Lam, S., Ramos, Y., Mohan, A., et al. (2006). Inactivation of the p53 pathway in retinoblastoma. Nature 444, 61-66.
73. Lee, W. H., Bookstein, R., Hong, F., Young, L. J., Shew, J. Y., and Lee, E. Y. (1987). Human retinoblastoma susceptibility gene: cloning, identification, and sequence. Science 235, 1394-1399.
74. Lewis, P. W., Beall, E. L., Fleischer, T. C., Georlette, D., Link, A. J., and Botchan, M. R. (2004). Identification of a Drosophila Myb-E2F2/ RBF transcriptional repressor complex. Genes Dev 18, 2929-2940.
75. Li, B., Gordon, G. M., Du, C. H., Xu, J., and Du, W. (2010). Specific killing of Rb mutant cancer cells by inactivating TSC2. Cancer Cell 17, 469-480.
76. Li, J., Ran, C., Li, E., Gordon, F., Comstock, G., Siddiqui, H., Cleghorn, W., Chen, H. Z., Kornacker, K., Liu, C. G., et al. (2008). Synergistic function of E2F7 and E2F8 is essential for cell survival and embryonic development. Dev Cell 14, 62-75.
77. Lin, W., Cao, J., Liu, J., Beshiri, M. L., Fujiwara, Y., Francis, J., Cherniack, A. D., Geisen, C., Blair, L. P., Zou, M. R., et al. (2011). Loss of the retinoblastoma binding protein 2 (RBP2) histone demethylase suppresses tumorigenesis in mice lacking Rb1 or Men1. Proc Natl Acad Sci U S A 108, 13379-13386.
78. Litovchick, L., Florens, L. A., Swanson, S. K., Washburn, M. P., and DeCaprio, J. A. (2011). DYRK1A protein kinase promotes quiescence and senescence through DREAM complex assembly. Genes Dev 25, 801-813.
79. Litovchick, L., Sadasivam, S., Florens, L., Zhu, X., Swanson, S. K., Velmurugan, S., Chen, R., Washburn, M. P., Liu, X. S., and DeCaprio, J. A. (2007). Evolutionarily conserved multisubunit RBL2/p130 and E2F4 protein complex represses human cell cycle-dependent genes in quiescence. Mol Cell 26, 539-551.
80. Longworth, M. S., Herr, A., Ji, J. Y., and Dyson, N. J. (2008). RBF1 promotes chromatin condensation through a conserved interaction with the Condensin II protein dCAP-D3. Genes Dev 22, 1011-1024.
81. Lopez-Bigas, N., Kisiel, T. A., Dewaal, D. C., Holmes, K. B., Volkert, T. L., Gupta, S., Love, J., Murray, H. L., Young, R. A., and Benevolenskaya, E. V. (2008). Genome-wide analysis of the H3K4 histone demethylase RBP2 reveals a transcriptional program controlling differentiation. Mol Cell 31, 520-530.
82. Ludlow, J. W., Glendening, C. L., Livingston, D. M., and DeCarprio, J. A. (1993). Specific enzymatic dephosphorylation of the retinoblastoma protein. Mol Cell Biol 13, 367-372.
83. Lukas, J., Parry, D., Aagaard, L., Mann, D. J., Bartkova, J., Strauss, M., Peters, G., and Bartek, J. (1995). Retinoblastoma-proteindependent cell-cycle inhibition by the tumour suppressor p16. Nature 375, 503-506.
84. Magnaghi-Jaulin, L., Groisman, R., Naguibneva, I., Robin, P., Lorain, S., Le Villain, J. P., Troalen, F., Trouche, D., and Harel-Bellan, A. (1998). Retinoblastoma protein represses transcription by recruiting a histone deacetylase. Nature 391, 601-605.
85. Manning, A. L., Longworth, M. S., and Dyson, N. J. (2010). Loss of pRB causes centromere dysfunction and chromosomal instability. Genes Dev 24, 1364-1376.
86. Milet, C., Rincheval-Arnold, A., Mignotte, B., and Guénal, I. (2010). The Drosophila retinoblastoma protein induces apoptosis in proliferating but not in post-mitotic cells. Cell Cycle 9, 97-103.
87. Miller, C. W., Simon, K., Aslo, A., Kok, K., Yokota, J., Buys, C. H., Terada, M., and Koeffler, H. P. (1992). p53 mutations in human lung tumors. Cancer Res 52, 1695-1698.
88. Moon, N. S., Di Stefano, L., and Dyson, N. (2006). A gradient of epidermal growth factor receptor signaling determines the sensitivity of rbf1 mutant cells to E2F-dependent apoptosis. Mol Cell Biol 26, 7601-7615.
89. Moon, N. S., Frolov, M. V., Kwon, E. J., Di Stefano, L., Dimova, D. K., Morris, E. J., Taylor-Harding, B., White, K., and Dyson, N. J. (2005). Drosophila E2F1 has context-specific pro- and antiapoptotic properties during development. Dev Cell 9, 463-475.
90. Moroni, M. C., Hickman, E. S., Lazzerini Denchi, E., Caprara, G., Colli, E., Cecconi, F., Müller, H., and Helin, K. (2001). Apaf-1 is a transcriptional target for E2F and p53. Nat Cell Biol 3, 552-558.
91. Müller, H., Bracken, A. P., Vernell, R., Moroni, M. C., Christians, F., Grassilli, E., Prosperini, E., Vigo, E., Oliner, J. D., and Helin, K. (2001). E2Fs regulate the expression of genes involved in differentiation, development, proliferation, and apoptosis. Genes Dev 15, 267-285.
92. Mulligan, G., and Jacks, T. (1998). The retinoblastoma gene family: cousins with overlapping interests. Trends Genet 14, 223-229.
93. Narita, M., Nũnez, S., Heard, E., Narita, M., Lin, A. W., Hearn, S. A., Spector, D. L., Hannon, G. J., and Lowe, S. W. (2003). Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence. Cell 113, 703-716.
94. Nicolay, B. N., Bayarmagnai, B., Islam, A. B., Lopez-Bigas, N., and Frolov, M. V. (2011). Cooperation between dE2F1 and Yki/Sd defines a distinct transcriptional program necessary to bypass cell cycle exit. Genes Dev 25, 323-335.
95. Nicolay, B. N., Bayarmagnai, B., Moon, N. S., Benevolenskaya, E. V., and Frolov, M. V. (2010). Combined inactivation of pRB and hippo pathways induces dedifferentiation in the Drosophila retina. PLoS Genet 6, e1000918.
96. Nogueira, V., Park, Y., Chen, C. C., Xu, P. Z., Chen, M. L., Tonic, I., Unterman, T., and Hay, N. (2008). Akt determines replicative senescence and oxidative or oncogenic premature senescence and sensitizes cells to oxidative apoptosis. Cancer Cell 14, 458-470.
97. Ozcan, U., Ozcan, L., Yilmaz, E., Düvel, K., Sahin, M., Manning, B. D., and Hotamisligil, G. S. (2008). Loss of the tuberous sclerosis complex tumor suppressors triggers the unfolded protein response to regulate insulin signaling and apoptosis. Mol Cell 29, 541-551.
98. Pan, D. (2010). The hippo signaling pathway in development and cancer. Dev Cell 19, 491-505.
99. Pearson, M., Carbone, R., Sebastiani, C., Cioce, M., Fagioli, M., Saito, S., Higashimoto, Y., Appella, E., Minucci, S., Pandolfi, P. P., et al. (2000). PML regulates p53 acetylation and premature senescence induced by oncogenic Ras. Nature 406, 207-210.
100. Pickering, M. T., and Kowalik, T. F. (2006). Rb inactivation leads to E2F1-mediated DNA double-strand break accumulation. Oncogene 25, 746-755.
101. Polyak, K., Lee, M. H., Erdjument-Bromage, H., Koff, A., Roberts, J. M., Tempst, P., and Massagué, J. (1994). Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 78, 59-66.
102. Qin, X. Q., Chittenden, T., Livingston, D. M., and Kaelin, W. G. Jr. (1992). Identification of a growth suppression domain within the retinoblastoma gene product. Genes Dev 6, 953-964.
103. Racek, T., Buhlmann, S., Rüst, F., Knoll, S., Alla, V., and Pützer, B. M. (2008). Transcriptional repression of the prosurvival endoplasmic reticulum chaperone GRP78/BIP by E2F1. J Biol Chem 283, 34305-34314.
104. Ren, B., Cam, H., Takahashi, Y., Volkert, T., Terragni, J., Young, R. A., and Dynlacht, B. D. (2002). E2F integrates cell cycle progression with DNA repair, replication, and G(2)/M checkpoints. Genes Dev 16, 245-256.
105. Robertson, K. D., Ait-Si-Ali, S., Yokochi, T., Wade, P. A., Jones, P. L., and Wolffe, A. P. (2000). DNMT1 forms a complex with Rb, E2F1 and HDAC1 and represses transcription from E2F-responsive promoters. Nat Genet 25, 338-342.
106. Rogoff, H. A., Pickering, M. T., Debatis, M. E., Jones, S., and Kowalik, T. F. (2002). E2F1 induces phosphorylation of p53 that is coincident with p53 accumulation and apoptosis. Mol Cell Biol 22, 5308-5318.
107. Rubin, S. M., Gall, A. L., Zheng, N., and Pavletich, N. P. (2005). Structure of the Rb C-terminal domain bound to E2F1-DP1: a mechanism for phosphorylation-induced E2F release. Cell 123, 1093-1106.
108. Ruthenburg, A. J., Li, H., Patel, D. J., and Allis, C. D. (2007). Multivalent engagement of chromatin modifications by linked binding modules. Nat Rev Mol Cell Biol 8, 983-994.
109. Sage, J., Miller, A. L., Pérez-Mancera, P. A., Wysocki, J. M., and Jacks, T. (2003). Acute mutation of retinoblastoma gene function is sufficient for cell cycle re-entry. Nature 424, 223-228.
110. Sarbassov, D. D., Guertin, D. A., Ali, S. M., and Sabatini, D. M. (2005). Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 307, 1098-1101.
111. Schvartzman, J. M., Duijf, P. H., Sotillo, R., Coker, C., and Benezra, R. (2011). Mad2 is a critical mediator of the chromosome instability observed upon Rb and p53 pathway inhibition. Cancer Cell 19, 701-714.
112. Searle, J. S., Li, B., and Du, W. (2010). Targeting Rb mutant cancers by inactivating TSC2. Oncotarget 1, 228-232.
113. Serrano, M., Hannon, G. J., and Beach, D. (1993). A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 366, 704-707.
114. Shah, O. J., Wang, Z., and Hunter, T. (2004). Inappropriate activation of the TSC/Rheb/mTOR/S6K cassette induces IRS1/2 depletion, insulin resistance, and cell survival deficiencies. Curr Biol 14, 1650-1656.
115. Sharma, A., Yeow, W. S., Ertel, A., Coleman, I., Clegg, N., Thangavel, C., Morrissey, C., Zhang, X., Comstock, C. E., Witkiewicz, A. K., et al. (2010). The retinoblastoma tumor suppressor controls androgen signaling and human prostate cancer progression. J Clin Invest 120, 4478-4492.
116. Sherr, C. J., and McCormick, F. (2002). The RB and p53 pathways in cancer. Cancer Cell 2, 103-112.
117. Stanelle, J., Stiewe, T., Theseling, C. C., Peter, M., and Pützer, B. M. (2002). Gene expression changes in response to E2F1 activation. Nucleic Acids Res 30, 1859-1867.
118. Steele, L., Sukhanova, M. J., Xu, J., Gordon, G. M., Huang, Y., Yu, L., and Du, W. (2009). Retinoblastoma family protein promotes normal R8-photoreceptor differentiation in the absence of rhinoceros by inhibiting dE2F1 activity. Dev Biol 335, 228-236.
119. Stevaux, O., Dimova, D., Frolov, M. V., Taylor-Harding, B., Morris, E., and Dyson, N. (2002). Distinct mechanisms of E2F regulation by Drosophila RBF1 and RBF2. EMBO J 21, 4927-4937.
120. Stirzaker, C., Millar, D. S., Paul, C. L., Warnecke, P. M., Harrison, J., Vincent, P. C., Frommer, M., and Clark, S. J. (1997). Extensive DNA methylation spanning the Rb promoter in retinoblastoma tumors. Cancer Res 57, 2229-2237.
121. Stott, F. J., Bates, S., James, M. C., McConnell, B. B., Starborg, M., Brookes, S., Palmero, I., Ryan, K., Hara, E., Vousden, K. H., et al. (1998). The alternative product from the human CDKN2A locus, p14(ARF), participates in a regulatory feedback loop with p53 and MDM2. EMBO J 17, 5001-5014.
122. Sukhanova, M. J., Steele, L. J., Zhang, T., Gordon, G. M., and Du, W. RBF and Rno promote photoreceptor differentiation onset through modulating EGFR signaling in the Drosophila developing eye. Dev Biol. Sep 2, 2011. [Epub ahead of print].
123. Takahashi, Y., Rayman, J. B., and Dynlacht, B. D. (2000). Analysis of promoter binding by the E2F and pRB families in vivo: distinct E2F proteins mediate activation and repression. Genes Dev 14, 804-816.
124. Talluri, S., Isaac, C. E., Ahmad, M., Henley, S. A., Francis, S. M., Martens, A. L., Bremner, R., and Dick, F. A. (2010). A G1 checkpoint mediated by the retinoblastoma protein that is dispensable in terminal differentiation but essential for senescence. Mol Cell Biol 30, 948-960.
125. Tanaka, H., Matsumura, I., Ezoe, S., Satoh, Y., Sakamaki, T., Albanese, C., Machii, T., Pestell, R. G., and Kanakura, Y. (2002). E2F1 and c-Myc potentiate apoptosis through inhibition of NFkappaB activity that facilitates MnSOD-mediated ROS elimination. Mol Cell 9, 1017-1029.
126. Tanaka-Matakatsu, M., Xu, J., Cheng, L., and Du, W. (2009). Regulation of apoptosis of rbf mutant cells during Drosophila development. Dev Biol 326, 347-356.
127. Taubert, S., Gorrini, C., Frank, S. R., Parisi, T., Fuchs, M., Chan, H. M., Livingston, D. M., and Amati, B. (2004). E2F-dependent histone acetylation and recruitment of the Tip60 acetyltransferase complex to chromatin in late G1. Mol Cell Biol 24, 4546-4556.
128. Taylor, B. S., Schultz, N., Hieronymus, H., Gopalan, A., Xiao, Y., Carver, B. S., Arora, V. K., Kaushik, P., Cerami, E., Reva, B., et al. (2010). Integrative genomic profiling of human prostate cancer. Cancer Cell 18, 11-22.
129. Thomas, D. M., Carty, S. A., Piscopo, D. M., Lee, J. S., Wang, W. F., Forrester, W. C., and Hinds, P. W. (2001). The retinoblastoma protein acts as a transcriptional coactivator required for osteogenic differentiation. Mol Cell 8, 303-316.
130. Toyoshima, H., and Hunter, T. (1994). p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21. Cell 78, 67-74.
131. Treins, C., Warne, P. H., Magnuson, M. A., Pende, M., and Downward, J. (2010). Rictor is a novel target of p70 S6 kinase-1. Oncogene 29, 1003-1016.
132. Tsai, K. Y., Hu, Y., Macleod, K. F., Crowley, D., Yamasaki, L., and Jacks, T. (1998). Mutation of E2f-1 suppresses apoptosis and inappropriate S phase entry and extends survival of Rb-deficient mouse embryos. Mol Cell 2, 293-304.
133. Tschöp, K., Conery, A. R., Litovchick, L., Decaprio, J. A., Settleman, J., Harlow, E., and Dyson, N. (2011). A kinase shRNA screen links LATS2 and the pRB tumor suppressor. Genes Dev 25, 814-830.
134. van den Heuvel, S., and Dyson, N. J. (2008). Conserved functions of the pRB and E2F families. Nat Rev Mol Cell Biol 9, 713-724.
135. van Harn, T., Foijer, F., van Vugt, M., Banerjee, R., Yang, F., Oostra, A., Joenje, H., and te Riele, H. (2010). Loss of Rb proteins causes genomic instability in the absence of mitogenic signaling. Genes Dev 24, 1377-1388.
136. Vernier, M., Bourdeau, V., Gaumont-Leclerc, M. F., Moiseeva, O., Bégin, V., Saad, F., Mes-Masson, A. M., and Ferbeyre, G. (2011). Regulation of E2Fs and senescence by PML nuclear bodies. Genes Dev 25, 41-50.
137. Voas, M. G., and Rebay, I. (2003). The novel plant homeodomain protein rhinoceros antagonizes Ras signaling in the Drosophila eye. Genetics 165, 1993-2006.
138. Wang, H., Bauzon, F., Ji, P., Xu, X., Sun, D., Locker, J., Sellers, R. S., Nakayama, K., Nakayama, K. I., Cobrinik, D., et al. (2010). Skp2 is required for survival of aberrantly proliferating Rb1-deficient cells and for tumorigenesis in Rb1 +/- mice. Nat Genet 42, 83-88.
139. Wei, W., Ayad, N. G., Wan, Y., Zhang, G. J., Kirschner, M. W., and Kaelin, W. G. Jr. (2004). Degradation of the SCF component Skp2 in cell-cycle phase G1 by the anaphase-promoting complex. Nature 428, 194-198.
140. Wikenheiser-Brokamp, K. A. (2004). Rb family proteins differentially regulate distinct cell lineages during epithelial development. Development 131, 4299-4310.
141. Wikenheiser-Brokamp, K. A. (2006a). Retinoblastoma family proteins: insights gained through genetic manipulation of mice. Cell Mol Life Sci 63, 767-780.
142. Wikenheiser-Brokamp, K. A. (2006b). Retinoblastoma regulatory pathway in lung cancer. Curr Mol Med 6, 783-793.
143. Williams, B. O., Remington, L., Albert, D. M., Mukai, S., Bronson, R. T., and Jacks, T. (1994). Cooperative tumorigenic effects of germline mutations in Rb and p53. Nat Genet 7, 480-484.
144. Wirt, S. E., Adler, A. S., Gebala, V., Weimann, J. M., Schaffer, B. E., Saddic, L. A., Viatour, P., Vogel, H., Chang, H. Y., Meissner, A., et al. (2010). G1 arrest and differentiation can occur independently of Rb family function. J Cell Biol 191, 809-825.
145. Xie, W., Jiang, P., Miao, L., Zhao, Y., Zhimin, Z., Qing, L., Zhu, W. G., and Wu, M. (2006). Novel link between E2F1 and Smac/DIABLO: proapoptotic Smac/DIABLO is transcriptionally upregulated by E2F1. Nucleic Acids Res 34, 2046-2055.
146. Yamasaki, L., Bronson, R., Williams, B. O., Dyson, N. J., Harlow, E., and Jacks, T. (1998). Loss of E2F-1 reduces tumorigenesis and extends the lifespan of Rb1(+/-) mice. Nat Genet 18, 360-364.
147. Yamasaki, L., Jacks, T., Bronson, R., Goillot, E., Harlow, E., and Dyson, N. J. (1996). Tumor induction and tissue atrophy in mice lacking E2F-1. Cell 85, 537-548.
148. Young, A. P., and Longmore, G. D. (2004). Ras protects Rb family null fibroblasts from cell death: a role for AP-1. J Biol Chem 279, 10931-10938.
149. Zhang, H. S., Gavin, M., Dahiya, A., Postigo, A. A., Ma, D., Luo, R. X., Harbour, J. W., and Dean, D. C. (2000). Exit from G1 and S phase of the cell cycle is regulated by repressor complexes containing HDAC-Rb-hSWI/SNF and Rb-hSWI/SNF. Cell 101, 79-89.
150. Zhang, Y., Xiong, Y., and Yarbrough, W. G. (1998). ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways. Cell 92, 725-734.
151. Zhu, L., Harlow, E., and Dynlacht, B. D. (1995). p107 uses a p21CIP1-related domain to bind cyclin/cdk2 and regulate interactions with E2F. Genes Dev 9, 1740-1752.